Does inflammation contribute to thrombotic events?

Haemostasis

Volumn 30, Issue SUPPL. 2, 2000, Pages 34-40

  Esmon, Charles T ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Coagulation; Endothelial cell protein C receptor; Inflammation; Thrombomodulin; Thrombosis

Indexed keywords

ACUTE PHASE PROTEIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; BLOOD CLOTTING FACTOR 9A; ENDOTOXIN; FIBRINOGEN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD CLOTTING; BLOOD FLOW; COMPLEMENT ACTIVATION; CYTOKINE RELEASE; HUMAN; INFLAMMATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; THROMBOGENESIS; THROMBOSIS;

EID: 0034461642     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054161     Document Type: Article

References (35)

1. Procoagulant response of the endothelium and monocytes
2. On the mechanism by which complement proteins C5b-9 increase platelet prothrombinase activity
3. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells
4. Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor
5. Plasma thrombomodulin in health and diseases
6. Release of thrombomodulin from endothelial cells by concerted action of TNF-α and neutrophils: In vivo and in vitro studies
7. Modulation of human endothelial thrombomodulin by neutrophils and their release products
8. Cytokines: Triggers of clinical thrombotic disease
9. Lack of suppressed renal thrombomodulin expression in a septic rat model with glomerular thrombotic microangiopathy
10. Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo
11. Functional characterization of 5′-flanking region of the mouse endothelial protein C receptor (EPCR) gene
12. Isolation and characterization of the glycosaminoglycan component of rabbit thrombomodulin proteoglycan
13. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex
14. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex
15. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a)
16. Cytokines, platelet production and hemostasis
17. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein
18. Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating Type I and Type III deficiences to be phenotypic variants of the same genetic disease
19. Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S
20. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
21. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression
22. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor
23. Plasminogen activator inhibitors
24. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets
25. The biology of P-selectin glycoprotein ligand-1: Its role as a selectin counter-receptor in leukocyte-endothelial and leukocyte-platelet interaction
26. Effects of interleukin 6 on megakaryoctyes and on canine platelet function
27. Differential effects of anti-β-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C
28. On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies
29. Plasma thrombomodulin in Wegener's granulomatosis as an indicator of vascular injuries
30. Thrombin receptor function and cardiovascular disease
31. Cell mediated events that control blood coagulation and vascular injury
32. Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans
33. A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: A Southwest Oncology Group study
34. Infusion of phospholipid vesicles amplifies the local thrombotic response to TNF and anti-protein C into a consumptive response
35. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa